Skip to main content

. 1958 Oct;34(5):817–833.

Hypertensive Vascular Disease as a Consequence of Increased Arterial Pressure

Quantitative Study in Rats with Hydralazine-Treated Renal Hypertension*

G M C Masson, L J McCormack, H P Dustan, A C Corcoran

PMCID: PMC1934754 PMID: 13571375

817

Images in this article

Fig. 1
on p.831

Fig. 2
on p.831

Fig. 3
on p.831

Fig. 4
on p.831

Fig. 5
on p.831

Fig. 6
on p.831

Fig. 7
on p.833

Fig. 8
on p.833

Fig. 9
on p.833

Fig. 10
on p.833

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

DEL GRECO F., OLMSTED F., MASSON G. M., CORCORAN A. C. Graphic measurement of arterial pressure in the unanesthetized rat; an improved method. J Lab Clin Med. 1953 May;41(5):729–737. [PubMed] [Google Scholar]
DUSTAN H. P., TAYLOR R. D., CORCORAN A. C. Rheumatic and febrile syndrome during prolonged hydralazine treatment. J Am Med Assoc. 1954 Jan 2;154(1):23–29. doi: 10.1001/jama.1954.02940350025006. [DOI] [PubMed] [Google Scholar]
GAUNT R., ANTONCHAK N., MILLER G. J., RENZI A. A. Effect of reserpine (serpasil) and hydralazine (apresoline) on experimental steroid hypertension. Am J Physiol. 1955 Jul;182(1):63–68. doi: 10.1152/ajplegacy.1955.182.1.63. [DOI] [PubMed] [Google Scholar]
GREEN D. M., SAUNDERS F. J., WAHLGREN N., CRAIG R. L. Self-sustaining, post-DCA hypertensive cardiovascular disease. Am J Physiol. 1952 Jul;170(1):94–106. doi: 10.1152/ajplegacy.1952.170.1.94. [DOI] [PubMed] [Google Scholar]
KOLETSKY S. Necrotizing vascular disease in rat. I. Observations on pathogenesis. AMA Arch Pathol. 1955 Mar;59(3):312–320. [PubMed] [Google Scholar]
NEEFE J. R., GAMBESCIA J. M., KURTZ C. H., SMITH H. D., BEEBE G. W., JABLON S., REINHOLD J. G., WILLIAMS S. C. Prevalence and nature of hepatic disturbance following acute viral hepatitis with jaundice. Ann Intern Med. 1955 Jul;43(1):1–32. doi: 10.7326/0003-4819-43-1-1. [DOI] [PubMed] [Google Scholar]
TAYLOR R. D., CORCORAN A. C., DUSTAN H. P., PAGE I. H. Further evaluation of hydralazine in treatment of hypertensive disease. AMA Arch Intern Med. 1954 May;93(5):705–712. doi: 10.1001/archinte.1954.00240290063007. [DOI] [PubMed] [Google Scholar]

ACTIONS

PDF (3.1 MB)

RESOURCES